Pharma acquisition news: US-based Charles River Laboratories International has agreed to acquire non-clinical contract research organization (CRO) MPI Research for about $800 million. Based in Michigan, MPI offers comprehensive testing services to biopharma and medical device companies across the world. The Massachusetts-based Charles River, on the other hand, provides a variety of pre-clinical and clinical […]

The post Charles River to acquire MPI Research for $800m appeared first on Business News Today.